-
Share
354 Posts.
51
01/03/21
12:34
Share
This is an excerpt from the About section of one of their latest ASX announcements...
”Chimeric Therapeutics is currently in a phase 1 clinical trial for its lead asset, CLTX-CAR T. “
It clearly states in the trial.
-